Insider Transactions in Q4 2025 at Cullinan Oncology, Inc. (CGEM)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2025
|
Nadim Ahmed President and CEO |
SELL
Open market or private sale
|
Direct |
9,922
-2.3%
|
$99,220
$10.01 P/Share
|
|
Dec 19
2025
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,345
-1.0%
|
$13,450
$10.01 P/Share
|
|
Dec 18
2025
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,898
-2.12%
|
$26,082
$9.67 P/Share
|
|
Dec 18
2025
|
Jeffrey Alan Jones Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,632
-2.66%
|
$41,688
$9.67 P/Share
|
|
Dec 18
2025
|
Jacquelyn L Sumer Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,480
-2.51%
|
$31,320
$9.67 P/Share
|
|
Dec 15
2025
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
995
-0.72%
|
$10,945
$11.9 P/Share
|
|
Dec 12
2025
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,148
-1.53%
|
$25,776
$12.38 P/Share
|
|
Nov 24
2025
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,000
-2.82%
|
$48,000
$12.3 P/Share
|
|
Oct 28
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
165,667
+1.81%
|
$1,325,336
$8.4 P/Share
|
|
Oct 17
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
32,217
+0.36%
|
$225,519
$7.84 P/Share
|
|
Oct 16
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,000
+1.68%
|
$1,200,000
$8.86 P/Share
|
|
Oct 15
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
51,500
+0.59%
|
$360,500
$7.94 P/Share
|
|
Oct 14
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,032
+0.18%
|
$105,224
$7.59 P/Share
|
|
Oct 10
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
277,298
+3.14%
|
$1,941,086
$7.36 P/Share
|
|
Oct 09
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
626,043
+7.04%
|
$3,756,258
$6.7 P/Share
|
|
Oct 08
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
556,300
+6.78%
|
$3,337,800
$6.46 P/Share
|